Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Merkley + Partners has eliminated about a dozen positions largely to compensate for the loss of Pfizer’s Lipitor business, the Omnicom Group agency confirmed.
Roughly half the cuts were achieved through layoffs; the rest involved closing out vacant jobs. The cuts equated to roughly 5 percent of the New York agency’s total staff, which is estimated at 260.
Lipitor, with billings of $60-80 million, is still in review, but the New York client eliminated Merkley 2 1/2 months ago in an earlier round [Adweek Online, Sept.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in